Coagulation (blood clotting) results from a sequence (cascade) of reactions involving the coagulation factors. Some of these factors have other names, for example, Factor I (fibrinogen), Factor II (prothrombin), and Factor XII (Hageman factor).
Most of these proteins are produced in the liver and secreted into the blood. Some of the Factors (that is, II, VII, IX, and X) require Vitamin K for their synthesis. Warfarin (Coumadin) is a commonly-used "anticoagulant" drug. It acts in the liver by inhibiting the enzyme that requires Vitamin K.
The coagulation sequence is initiated when some of the coagulation factors contact damaged tissue. Each coagulation factor reaction triggers the next reaction in the cascade. The final product of the coagulation cascade is the fibrin clot (blood clot).
Substances that inhibit the action of the coagulation factors, and plasmin, which eventually lyses (breaks down) the fibrin clot, are activated by the damaged tissue at the same time as the coagulation factors. However, they function more slowly and over a longer period of time than the coagulation factors.
This allows a clot to form to stop bleeding, then the clot is dissolved (after enough time for the tissue to heal) to restore blood flow. One major coagulation inhibitor is antithrombin III, a protein that requires endogenous (made in the body) heparin for its activity.
Veins and arteries vary in size from one patient to another and from one side of the body to the other. Obtaining a blood sample from some people may be more difficult than from others.
|